Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
ABOUT THIS PAGE
82
PharmaCompass offers a list of Krypton-81 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Krypton-81 manufacturer or Krypton-81 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Krypton-81 manufacturer or Krypton-81 supplier.
PharmaCompass also assists you with knowing the Krypton-81 API Price utilized in the formulation of products. Krypton-81 API Price is not always fixed or binding as the Krypton-81 Price is obtained through a variety of data sources. The Krypton-81 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Krypton-81 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Krypton-81, including repackagers and relabelers. The FDA regulates Krypton-81 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Krypton-81 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Krypton-81 supplier is an individual or a company that provides Krypton-81 active pharmaceutical ingredient (API) or Krypton-81 finished formulations upon request. The Krypton-81 suppliers may include Krypton-81 API manufacturers, exporters, distributors and traders.
click here to find a list of Krypton-81 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Krypton-81 DMF (Drug Master File) is a document detailing the whole manufacturing process of Krypton-81 active pharmaceutical ingredient (API) in detail. Different forms of Krypton-81 DMFs exist exist since differing nations have different regulations, such as Krypton-81 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Krypton-81 DMF submitted to regulatory agencies in the US is known as a USDMF. Krypton-81 USDMF includes data on Krypton-81's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Krypton-81 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Krypton-81 suppliers with USDMF on PharmaCompass.
Krypton-81 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Krypton-81 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Krypton-81 GMP manufacturer or Krypton-81 GMP API supplier for your needs.
A Krypton-81 CoA (Certificate of Analysis) is a formal document that attests to Krypton-81's compliance with Krypton-81 specifications and serves as a tool for batch-level quality control.
Krypton-81 CoA mostly includes findings from lab analyses of a specific batch. For each Krypton-81 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Krypton-81 may be tested according to a variety of international standards, such as European Pharmacopoeia (Krypton-81 EP), Krypton-81 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Krypton-81 USP).
